Item 16. FORM 10-K SUMMARY

4K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

-110-


PART IV			Signatures
RESMED INC. AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DATED August 7, 2025

ResMed Inc.


/s/ MICHAEL J. FARRELL
Michael J. Farrell
Chief Executive Officer
(Principal Executive Officer)

-111-

Table of Contents


PART IV			Signatures
RESMED INC. AND SUBSIDIARIES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.


SIGNATURE	TITLE	DATE

/S/ MICHAEL J. FARRELL	Chief Executive Officer and Chairman	August 7, 2025
Michael J. Farrell	(Principal Executive Officer)

/S/ BRETT A. SANDERCOCK	Chief Financial Officer	August 7, 2025
Brett A. Sandercock	(Principal Financial Officer and Principal Accounting Officer)

/S/ PETER C. FARRELL	Director and Chair Emeritus	August 7, 2025
Peter C. Farrell

/S/ CAROL J. BURT	Director	August 7, 2025
Carol J. Burt

/S/ CHRISTOPHER DELOREFICE	Director	August 7, 2025
Christopher DelOrefice

/S/ KAREN DREXLER	Director	August 7, 2025
Karen Drexler

/S/ HARJIT GILL	Director	August 7, 2025
Harjit Gill

/S/ JOHN HERNANDEZ	Director	August 7, 2025
John Hernandez

/S/ RICHARD SULPIZIO	Director	August 7, 2025
Richard Sulpizio

/S/ DESNEY TAN	Director	August 7, 2025
Desney Tan

/S/ RON TAYLOR	Director	August 7, 2025
Ron Taylor

/S/ JAN DE WITTE	Director	August 7, 2025
Jan De Witte

-112-

Previous: Item 15. EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES